KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Interest Coverage Ratio (2018 - 2025)

Castle Biosciences' Interest Coverage Ratio history spans 7 years, with the latest figure at 159.46 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 678.77% year-over-year to 159.46; the TTM value through Dec 2025 reached 497.79, down 3412.86%, while the annual FY2025 figure was 497.79, 3412.86% down from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 159.46 at Castle Biosciences, up from 283.5 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 27.55 in Q4 2024 and bottomed at 15171.0 in Q4 2021.
  • The 5-year median for Interest Coverage Ratio is 1642.82 (2025), against an average of 3463.71.
  • The largest annual shift saw Interest Coverage Ratio tumbled 197543.3% in 2021 before it surged 100.97% in 2024.
  • A 5-year view of Interest Coverage Ratio shows it stood at 15171.0 in 2021, then skyrocketed by 62.38% to 5708.0 in 2022, then surged by 50.44% to 2829.0 in 2023, then soared by 100.97% to 27.55 in 2024, then tumbled by 678.77% to 159.46 in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Interest Coverage Ratio are 159.46 (Q4 2025), 283.5 (Q3 2025), and 202.43 (Q2 2025).